These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25573538)

  • 1. Pharmacological management of behavioral and psychiatric symptoms in older adults with intellectual disability.
    Eady N; Courtenay K; Strydom A
    Drugs Aging; 2015 Feb; 32(2):95-102. PubMed ID: 25573538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric Comorbidity in Older Adults with Intellectual Disability.
    Bratek A; Krysta K; Kucia K
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):590-593. PubMed ID: 28953835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
    Deutsch SI; Burket JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Practical guidelines for prescribing psychotropic medication to people with intellectual disability].
    de Kuijper G; Degraeve G; Zinkstok JR
    Tijdschr Psychiatr; 2019; 61(11):786-791. PubMed ID: 31907889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
    Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
    Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy in the treatment of subjects with intellectual disability.
    Häβler F; Thome J; Reis O
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S93-100. PubMed ID: 24858727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
    Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
    Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adults with intellectual disabilities in China: comorbid psychiatric disorder and its association with health service utilisation.
    He P; Chen G; Wang Z; Guo C; Li N; Yun C; Zheng X
    J Intellect Disabil Res; 2018 Feb; 62(2):106-114. PubMed ID: 29178565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability.
    Scheifes A; de Jong D; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2013 Oct; 34(10):3159-67. PubMed ID: 23886758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialist psychiatric health care utilization among older people with intellectual disability - predictors and comparisons with the general population: a national register study.
    Ahlström G; Axmon A; Sandberg M; Hultqvist J
    BMC Psychiatry; 2020 Feb; 20(1):70. PubMed ID: 32066421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication review using a Systematic Tool to Reduce Inappropriate Prescribing (STRIP) in adults with an intellectual disability: A pilot study.
    Zaal RJ; Ebbers S; Borms M; Koning Bd; Mombarg E; Ooms P; Vollaard H; van den Bemt PM; Evenhuis HM
    Res Dev Disabil; 2016 Aug; 55():132-42. PubMed ID: 27065309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription errors in older individuals with an intellectual disability: prevalence and risk factors in the Healthy Ageing and Intellectual Disability Study.
    Zaal RJ; van der Kaaij AD; Evenhuis HM; van den Bemt PM
    Res Dev Disabil; 2013 May; 34(5):1656-62. PubMed ID: 23501585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication and supplement use in older people with and without intellectual disability: An observational, cross-sectional study.
    Peklar J; Kos M; O'Dwyer M; McCarron M; McCallion P; Kenny RA; Henman MC
    PLoS One; 2017; 12(9):e0184390. PubMed ID: 28877256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.